ketorolac has been researched along with Cataract in 13 studies
Ketorolac: A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed)
ketorolac : A racemate comprising equimolar amounts of (R)-(+)- and (S)-(-)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. While only the (S)-(-) enantiomer is a COX1 and COX2 inhibitor, the (R)-(+) enantiomer exhibits potent analgesic activity. A non-steroidal anti-inflammatory drug, ketorolac is mainly used (generally as the tromethamine salt) for its potent analgesic properties in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It was withdrawn from the market in many countries in 1993 following association with haemorrhage and renal failure.
5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid : A member of the class of pyrrolizines that is 2,3-dihydro-1H-pyrrolizine which is substituted at positions 1 and 5 by carboxy and benzoyl groups, respectively.
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"To compare pain and the need for the opioid fentanyl use associated with the administration of phenylephrine 1." | 9.51 | Pain control and reduction of opioid use associated with intracameral phenylephrine1.0%-ketorolac 0.3% administered during cataract surgery. ( Donnenfeld, ED; Mychajlyszyn, A; Mychajlyszyn, D; Stein, R, 2022) |
"Participants scheduled for cataract removal were randomized to 1 of 5 anti-inflammatory prophylactic regimens: eye drops with a combination of prednisolone, 1%, and ketorolac tromethamine, 0." | 9.41 | Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial. ( Erichsen, JH; Forman, JL; Forslund Jacobsen, M; Holm, LM; Kessel, L, 2021) |
"A total 91 subjects scheduled to undergo cataract operation were randomized into three groups: Group 1, pre/postoperative bromfenac 0." | 9.20 | The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery. ( Chung, BH; Jung, JW; Kim, EK; Kim, TI; Seo, KY, 2015) |
"To assess the effectiveness of intracameral phenylephrine-ketorolac during cataract surgery compared with postoperative topical steroids in reducing the incidence of postoperative clinical cystoid macular edema (CME) confirmed via optical coherence tomography (OCT), breakthrough iritis, pain, and photophobia." | 7.96 | Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery. ( Bedi, R; Visco, DM, 2020) |
"3% was safe for use in children and maintained mydriasis during cataract surgery." | 6.94 | Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management. ( Plager, DA; Trivedi, RH; Wilson, ME, 2020) |
" On-label dosing of ketorolac (BID), bromfenac (BID), and nepafenac (TID) was instructed for 1 day prior to surgery." | 6.76 | A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification. ( Bucci, FA; Waterbury, LD, 2011) |
"To compare pain and the need for the opioid fentanyl use associated with the administration of phenylephrine 1." | 5.51 | Pain control and reduction of opioid use associated with intracameral phenylephrine1.0%-ketorolac 0.3% administered during cataract surgery. ( Donnenfeld, ED; Mychajlyszyn, A; Mychajlyszyn, D; Stein, R, 2022) |
"Participants scheduled for cataract removal were randomized to 1 of 5 anti-inflammatory prophylactic regimens: eye drops with a combination of prednisolone, 1%, and ketorolac tromethamine, 0." | 5.41 | Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial. ( Erichsen, JH; Forman, JL; Forslund Jacobsen, M; Holm, LM; Kessel, L, 2021) |
"A total 91 subjects scheduled to undergo cataract operation were randomized into three groups: Group 1, pre/postoperative bromfenac 0." | 5.20 | The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery. ( Chung, BH; Jung, JW; Kim, EK; Kim, TI; Seo, KY, 2015) |
"This study did not demonstrate a difference in the ability of diclofenac or ketorolac ophthalmic solutions to prevent PCO following cataract extraction and implantation of an intraocular lens." | 5.09 | Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation. ( Dolan, BJ; Flach, AJ, 2000) |
"Topical NSAIDs were found to be more effective in controlling CME, pain, iritis, and photophobia after cataract surgery compared with the intracanalicular dexamethasone insert in the presence of intracameral phenylephrine/ketorolac." | 4.31 | Comparison of postcataract surgery anti-inflammatory regimens on the incidence of cystoid macular edema, iritis, pain, and photophobia. ( Visco, DM, 2023) |
"To assess the effectiveness of intracameral phenylephrine-ketorolac during cataract surgery compared with postoperative topical steroids in reducing the incidence of postoperative clinical cystoid macular edema (CME) confirmed via optical coherence tomography (OCT), breakthrough iritis, pain, and photophobia." | 3.96 | Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery. ( Bedi, R; Visco, DM, 2020) |
"We report the antiinflammatory effect and efficacy of preoperative treatment with ketorolac in a patient with rheumatoid arthritis having phacoemulsification." | 3.71 | Antiinflammatory effect of preoperative ketorolac in phacoemulsification. ( Caronia, RM; Donnenfeld, ED; Perry, HD, 2002) |
"3% was safe for use in children and maintained mydriasis during cataract surgery." | 2.94 | Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management. ( Plager, DA; Trivedi, RH; Wilson, ME, 2020) |
" On-label dosing of ketorolac (BID), bromfenac (BID), and nepafenac (TID) was instructed for 1 day prior to surgery." | 2.76 | A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification. ( Bucci, FA; Waterbury, LD, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 6 (46.15) | 2.80 |
Authors | Studies |
---|---|
Donnenfeld, ED | 2 |
Mychajlyszyn, D | 1 |
Mychajlyszyn, A | 1 |
Stein, R | 1 |
Visco, DM | 2 |
Wingert, AM | 2 |
Liu, SH | 2 |
Lin, JC | 2 |
Sridhar, J | 2 |
Wilson, ME | 1 |
Trivedi, RH | 1 |
Plager, DA | 1 |
Bedi, R | 1 |
Erichsen, JH | 1 |
Holm, LM | 1 |
Forslund Jacobsen, M | 1 |
Forman, JL | 1 |
Kessel, L | 1 |
Mamalis, N | 1 |
Sullivan-Mackenna, D | 1 |
Roberts, H | 1 |
O'Brart, D | 1 |
Walter, KA | 1 |
Jung, JW | 1 |
Chung, BH | 1 |
Kim, EK | 1 |
Seo, KY | 1 |
Kim, TI | 1 |
Bucci, FA | 1 |
Waterbury, LD | 1 |
Caronia, RM | 1 |
Perry, HD | 1 |
Flach, AJ | 1 |
Dolan, BJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing U[NCT02132312] | Phase 3 | 78 participants (Actual) | Interventional | 2014-07-31 | Completed | ||
Effect of Drop-less Surgery Compared to Topical NSAID Alone and Combination of Steroid and NSAID on Central Macular Thickness After Cataract Surgery, a Randomized Controlled Trial[NCT03383328] | Phase 4 | 470 participants (Actual) | Interventional | 2018-02-01 | Completed | ||
The Effect of Preoperative Topical Ketorolac 0.45% on Aqueous Cytokine Levels and Macular Thickness in Diabetic and Non Diabetic Patients Undergoing Cataract Surgery[NCT02646072] | Phase 4 | 80 participants (Actual) | Interventional | 2014-08-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
"Mean AUC Analysis of Postoperative pain as measured using the Alder Hey Triage Pain Score at 3, 6, 9, and 24 hours after surgery. The primary analysis of Alder Hey Triage Pain Score was similar to the primary analysis of the change in pupil diameter using AUC. The Alder Hey Triage Pain Score identifies five categories of observations: voice/cry, facial expression, posture, movement, and color. Each of these has a possible score of 0, 1, or 2, resulting in a total score ranging between 0 and 10. A total score of zero means the subject experienced no pain, as the 5 categories added up totals zero. A total score of 10 means the subject experienced a lot of pain and is the worst possible outcome, as the 5 categories added up totals 10.~Parent responses in a diary with a score of 0, 1, or 2.~Cry or voice, 0=no compliant/cry, 1=Consolable, 2=Inconsolable~Facial Expression, 0=Normal, 1=Short grimace <50% of time, 2=Long grimace >50% of time~Posture, 0=Normal, 1=Touching/rub" (NCT02132312)
Timeframe: 24 hours
Intervention | score*hours (Mean) |
---|---|
OMS302 | 0.44 |
Phenylephrine HCl | 0.65 |
Mean Area-under-the-Curve (AUC) Analysis of Change From Baseline in Pupil Diameter (mm/min) During Surgery Excluding Subjects with In-evaluable Videos. (NCT02132312)
Timeframe: From surgery baseline (pre-incision) through surgery end (time of cortical clean-up/wound closure), the mean time of surgery duration is 35.46 minutes with a standard deviation of 19.98.
Intervention | millimeters*minutes (Mean) |
---|---|
OMS302 | 0.14 |
Phenylephrine HCl | 0.20 |
Safety as assessed by the incidence of adverse events and serious adverse events up until the last visit at Day 90. (NCT02132312)
Timeframe: 90 days
Intervention | Participants (Count of Participants) |
---|---|
OMS302 | 15 |
Phenylephrine HCl | 18 |
1 review available for ketorolac and Cataract
Article | Year |
---|---|
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu | 2022 |
6 trials available for ketorolac and Cataract
Article | Year |
---|---|
Pain control and reduction of opioid use associated with intracameral phenylephrine1.0%-ketorolac 0.3% administered during cataract surgery.
Topics: Analgesics, Opioid; Cataract; Double-Blind Method; Epinephrine; Fentanyl; Humans; Ketorolac; Pain; P | 2022 |
Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Child; Child, Preschool; Double-Blind Method; Hum | 2020 |
Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Cataract Extracti | 2021 |
The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extr | 2015 |
A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophe | 2011 |
Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Cataract Extraction; Chi | 2000 |
6 other studies available for ketorolac and Cataract
Article | Year |
---|---|
Comparison of postcataract surgery anti-inflammatory regimens on the incidence of cystoid macular edema, iritis, pain, and photophobia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Dexamethasone; Humans; Incidence; Iritis; Ketorol | 2023 |
Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Cataract Extraction; Cohort Studies; Humans; Irit | 2020 |
Importance of pupil dilation for cataract surgery.
Topics: Cataract; Cataract Extraction; Dilatation; Humans; Ketorolac; Mydriatics; Pain, Postoperative; Pheny | 2017 |
Reduction in surgical time and iris manipulation using continuous intracameral irrigation of phenylephrine and ketorolac to prevent miosis in FLACS.
Topics: Cataract; Humans; Iris; Ketorolac; Miosis; Operative Time; Phenylephrine | 2019 |
Reply.
Topics: Cataract; Humans; Iris; Ketorolac; Miosis; Operative Time; Phenylephrine | 2019 |
Antiinflammatory effect of preoperative ketorolac in phacoemulsification.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cataract; Drug Therapy, Combin | 2002 |